ID   STK11_HUMAN             Reviewed;         433 AA.
AC   Q15831; B2RBX7;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   05-OCT-2010, entry version 120.
DE   RecName: Full=Serine/threonine-protein kinase 11;
DE            EC=2.7.11.1;
DE   AltName: Full=Renal carcinoma antigen NY-REN-19;
DE   AltName: Full=Serine/threonine-protein kinase LKB1;
GN   Name=STK11; Synonyms=LKB1, PJS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RA   Nezu J.;
RL   Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   MEDLINE=98085866; PubMed=9425897; DOI=10.1038/ng0198-38;
RA   Jenne D.E., Reimann H., Nezu J., Friedl W., Loff S., Jeschke R.,
RA   Mueller O., Back W., Zimmer M.;
RT   "Peutz-Jeghers syndrome is caused by mutations in a novel serine
RT   threonine kinase.";
RL   Nat. Genet. 18:38-43(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=98196525; PubMed=9537235;
RA   Bignell G.R., Barfoot R., Seal S., Collins N., Warren W.,
RA   Stratton M.R.;
RT   "Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome
RT   gene in sporadic breast cancer.";
RL   Cancer Res. 58:1384-1386(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   MEDLINE=99438124; PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [8]
RP   IDENTIFICATION IN A TERNARY COMPLEX COMPOSED OF SMAD4 AND STK11IP, AND
RP   INTERACTION WITH SMAD4 AND STK11IP.
RX   MEDLINE=21617222; PubMed=11741830; DOI=10.1093/hmg/10.25.2869;
RA   Smith D.P., Rayter S.I., Niederlander C., Spicer J., Jones C.M.,
RA   Ashworth A.;
RT   "LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers
RT   syndrome kinase LKB1.";
RL   Hum. Mol. Genet. 10:2869-2877(2001).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH STRAD,
RP   AUTOPHOSPHORYLATION AT THR-336 AND THR-363, AND MUTAGENESIS OF
RP   ASP-176.
RX   MEDLINE=22688956; PubMed=12805220; DOI=10.1093/emboj/cdg292;
RA   Baas A.F., Boudeau J., Sapkota G.P., Smit L., Medema R., Morrice N.A.,
RA   Alessi D.R., Clevers H.C.;
RT   "Activation of the tumour suppressor kinase LKB1 by the STE20-like
RT   pseudokinase STRAD.";
RL   EMBO J. 22:3062-3072(2003).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF ASP-194, AND
RP   INTERACTION WITH STRAD AND CAB39.
RX   PubMed=14517248; DOI=10.1093/emboj/cdg490;
RA   Boudeau J., Baas A.F., Deak M., Morrice N.A., Kieloch A.,
RA   Schutkowski M., Prescott A.R., Clevers H.C., Alessi D.R.;
RT   "MO25alpha/beta interact with STRADalpha/beta enhancing their ability
RT   to bind, activate and localize LKB1 in the cytoplasm.";
RL   EMBO J. 22:5102-5114(2003).
RN   [11]
RP   INTERACTION WITH WDR6.
RX   PubMed=17216128; DOI=10.1007/s11010-006-9402-5;
RA   Xie X., Wang Z., Chen Y.;
RT   "Association of LKB1 with a WD-repeat protein WDR6 is implicated in
RT   cell growth arrest and p27(Kip1) induction.";
RL   Mol. Cell. Biochem. 301:115-122(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   VARIANT TESTICULAR TUMORS ASP-163.
RX   PubMed=9605748;
RA   Avizienyte E., Roth S., Loukola A., Hemminki A., Lothe R.A.,
RA   Stenwig A.E., Fossaa S.D., Salovaara R., Aaltonen L.A.;
RT   "Somatic mutations in LKB1 are rare in sporadic colorectal and
RT   testicular tumors.";
RL   Cancer Res. 58:2087-2090(1998).
RN   [15]
RP   VARIANT PJS ASN-247 DEL.
RX   MEDLINE=98431000; PubMed=9760200; DOI=10.1007/s004390050801;
RA   Nakagawa H., Koyama K., Miyoshi Y., Ando H., Baba S., Watatani M.,
RA   Yasutomi M., Matsuura N., Monden M., Nakamura Y.;
RT   "Nine novel germline mutations of STK11 in ten families with Peutz-
RT   Jeghers syndrome.";
RL   Hum. Genet. 103:168-172(1998).
RN   [16]
RP   VARIANTS PJS PRO-67 AND 303-ILE--GLN-306 DELINS ASN.
RX   MEDLINE=98089041; PubMed=9428765; DOI=10.1038/34432;
RA   Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S.,
RA   Loukola A., Bignell G., Warren W., Aminoff M., Hoeglund P.,
RA   Jaervinen H., Kristo P., Pelin K., Ridanpaeae M., Salovaara R.,
RA   Toro T., Bodmer W., Olschwang S., Olsen A.S., Stratton M.R.,
RA   de la Chapelle A., Aaltonen L.A.;
RT   "A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.";
RL   Nature 391:184-187(1998).
RN   [17]
RP   VARIANTS PJS 162-ASN--MET-164; ASN-194 AND LYS-297.
RX   MEDLINE=99335262; PubMed=10408777;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:6<476::AID-HUMU7>3.3.CO;2-U;
RA   Westerman A.M., Entius M.M., Boor P.P.C., Koole R., de Baar E.,
RA   Offerhaus G.J.A., Lubinski J., Lindhout D., Halley D.J.J.,
RA   de Rooij F.W.M., Wilson J.H.P.;
RT   "Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers
RT   families.";
RL   Hum. Mutat. 13:476-481(1999).
RN   [18]
RP   CHARACTERIZATION OF VARIANT TESTICULAR TUMORS ASP-163.
RX   PubMed=9887330; DOI=10.1093/hmg/8.1.45;
RA   Ylikorkala A., Avizienyte E., Tomlinson I.P., Tiainen M., Roth S.,
RA   Loukola A., Hemminki A., Johansson M., Sistonen P., Markie D.,
RA   Neale K., Phillips R., Zauber P., Twama T., Sampson J., Jaervinen H.,
RA   Maekelae T.P., Aaltonen L.A.;
RT   "Mutations and impaired function of LKB1 in familial and non-familial
RT   Peutz-Jeghers syndrome and a sporadic testicular cancer.";
RL   Hum. Mol. Genet. 8:45-51(1999).
RN   [19]
RP   VARIANTS MELANOMA ASP-49 AND ARG-135.
RX   PubMed=10201537; DOI=10.1046/j.1523-1747.1999.00551.x;
RA   Rowan A., Bataille V., MacKie R., Healy E., Bicknell D., Bodmer W.,
RA   Tomlinson I.;
RT   "Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic
RT   malignant melanomas.";
RL   J. Invest. Dermatol. 112:509-511(1999).
RN   [20]
RP   VARIANT MELANOMA TYR-194.
RX   PubMed=10208439; DOI=10.1038/sj.onc.1202486;
RA   Guldberg P., thor Straten P., Ahrenkiel V., Seremet T., Kirkin A.F.,
RA   Zeuthen J.;
RT   "Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in
RT   malignant melanoma.";
RL   Oncogene 18:1777-1780(1999).
RN   [21]
RP   VARIANTS PJS CYS-239 AND SER-315.
RX   PubMed=12372054; DOI=10.1034/j.1399-0004.2002.620405.x;
RA   Scott R.J., Crooks R., Meldrum C.J., Thomas L., Smith C.J.A.,
RA   Mowat D., McPhillips M., Spigelman A.D.;
RT   "Mutation analysis of the STK11/LKB1 gene and clinical characteristics
RT   of an Australian series of Peutz-Jeghers syndrome patients.";
RL   Clin. Genet. 62:282-287(2002).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-87.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Essential role in G1 cell cycle arrest. Phosphorylates
CC       and activates members of the AMPK-related subfamily of protein
CC       kinases. Tumor suppressor.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium or Manganese.
CC   -!- ENZYME REGULATION: Activated by binding of a complex consisting of
CC       CAB39 and STRAD or CAB39 and ALS2CR2.
CC   -!- SUBUNIT: Found in a ternary complex composed of SMAD4, STK11 and
CC       STK11IP. Interacts with SMAD4, STK11IP and WDR6.
CC   -!- INTERACTION:
CC       Q96CW1:AP2M1; NbExp=1; IntAct=EBI-306838, EBI-297683;
CC       Q9Y376:CAB39; NbExp=1; IntAct=EBI-306838, EBI-306905;
CC       Q14232:EIF2B1; NbExp=1; IntAct=EBI-306838, EBI-491065;
CC       Q96L34:MARK4; NbExp=2; IntAct=EBI-306838, EBI-302319;
CC       Q8TEW0:PARD3; NbExp=1; IntAct=EBI-306838, EBI-81968;
CC       Q7RTN6:STRADA; NbExp=3; IntAct=EBI-306838, EBI-1109114;
CC       Q9C0K7:STRADB; NbExp=2; IntAct=EBI-306838, EBI-306893;
CC       Q8NFZ5:TNIP2; NbExp=4; IntAct=EBI-306838, EBI-359372;
CC       Q9NNW5:WDR6; NbExp=1; IntAct=EBI-306838, EBI-1568315;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Relocates to the
CC       cytoplasm when bound to CAB39 and STRAD or CAB39 and ALS2CR2.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Strongest expression
CC       in testis and fetal liver.
CC   -!- PTM: Phosphorylated by a cAMP-dependent protein kinase (By
CC       similarity).
CC   -!- DISEASE: Defects in STK11 are a cause of Peutz-Jeghers syndrome
CC       (PJS) [MIM:175200]. PJS is a rare hereditary disease in which
CC       there is predisposition to benign and malignant tumors of many
CC       organ systems. PJS is an autosomal dominant disorder characterized
CC       by melanocytic macules of the lips, multiple gastrointestinal
CC       hamartomatous polyps and an increased risk for various neoplasms,
CC       including gastrointestinal cancer.
CC   -!- DISEASE: Defects in STK11 have been associated with testicular
CC       tumors (TEST) [MIM:273300]. A common solid malignancy in males.
CC       Germ cell tumors of the testis constitute 95% of all testicular
CC       neoplasms.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. LKB1 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/STK11ID292.html";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/STK11";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=PJS entry;
CC       URL="http://en.wikipedia.org/wiki/PJS";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF035625; AAC39527.1; -; mRNA.
DR   EMBL; U63333; AAB05809.1; -; mRNA.
DR   EMBL; AF032984; AAB97833.1; -; Genomic_DNA.
DR   EMBL; AF055327; AAC15742.1; -; Genomic_DNA.
DR   EMBL; AF055320; AAC15742.1; JOINED; Genomic_DNA.
DR   EMBL; AF055321; AAC15742.1; JOINED; Genomic_DNA.
DR   EMBL; AF055322; AAC15742.1; JOINED; Genomic_DNA.
DR   EMBL; AF055323; AAC15742.1; JOINED; Genomic_DNA.
DR   EMBL; AF055324; AAC15742.1; JOINED; Genomic_DNA.
DR   EMBL; AF055325; AAC15742.1; JOINED; Genomic_DNA.
DR   EMBL; AF055326; AAC15742.1; JOINED; Genomic_DNA.
DR   EMBL; AK314858; BAG37374.1; -; mRNA.
DR   EMBL; CH471139; EAW69540.1; -; Genomic_DNA.
DR   EMBL; BC007981; AAH07981.1; -; mRNA.
DR   EMBL; BC019334; AAH19334.1; -; mRNA.
DR   IPI; IPI00219072; -.
DR   RefSeq; NP_000446.1; -.
DR   UniGene; Hs.515005; -.
DR   PDB; 2WTK; X-ray; 2.65 A; C/F=43-347.
DR   PDBsum; 2WTK; -.
DR   ProteinModelPortal; Q15831; -.
DR   SMR; Q15831; 11-202, 46-329.
DR   DIP; DIP-31317N; -.
DR   IntAct; Q15831; 45.
DR   MINT; MINT-204048; -.
DR   STRING; Q15831; -.
DR   PhosphoSite; Q15831; -.
DR   PRIDE; Q15831; -.
DR   Ensembl; ENST00000326873; ENSP00000324856; ENSG00000118046.
DR   GeneID; 6794; -.
DR   KEGG; hsa:6794; -.
DR   UCSC; uc002lrl.1; human.
DR   CTD; 6794; -.
DR   GeneCards; GC19P001156; -.
DR   H-InvDB; HIX0014573; -.
DR   HGNC; HGNC:11389; STK11.
DR   HPA; CAB016231; -.
DR   HPA; CAB022105; -.
DR   HPA; HPA017254; -.
DR   MIM; 175200; phenotype.
DR   MIM; 273300; phenotype.
DR   MIM; 602216; gene.
DR   Orphanet; 2869; Peutz-Jeghers syndrome.
DR   PharmGKB; PA36198; -.
DR   eggNOG; prNOG05486; -.
DR   HOGENOM; HBG446083; -.
DR   HOVERGEN; HBG054467; -.
DR   InParanoid; Q15831; -.
DR   OMA; DTKDRWR; -.
DR   OrthoDB; EOG90CM2M; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_11163; Activated AMPK stimulates fatty-acid oxidation in muscle.
DR   Reactome; REACT_1505; Integration of energy metabolism.
DR   Reactome; REACT_498; Signaling by Insulin receptor.
DR   NextBio; 26541; -.
DR   ArrayExpress; Q15831; -.
DR   Bgee; Q15831; -.
DR   CleanEx; HS_STK11; -.
DR   Genevestigator; Q15831; -.
DR   GermOnline; ENSG00000118046; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046320; P:regulation of fatty acid oxidation; EXP:Reactome.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR015735; Ser/Thr_prot_kinase_STK.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF41; STK11; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell cycle; Complete proteome; Cytoplasm;
KW   Disease mutation; Kinase; Magnesium; Manganese; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    433       Serine/threonine-protein kinase 11.
FT                                /FTId=PRO_0000086699.
FT   DOMAIN       49    309       Protein kinase.
FT   NP_BIND      55     63       ATP (By similarity).
FT   ACT_SITE    176    176       Proton acceptor.
FT   BINDING      78     78       ATP (By similarity).
FT   MOD_RES      31     31       Phosphoserine.
FT   MOD_RES     336    336       Phosphothreonine; by autocatalysis.
FT   MOD_RES     363    363       Phosphothreonine; by autocatalysis.
FT   MOD_RES     428    428       Phosphoserine; by PKA (Potential).
FT   VARIANT      49     49       Y -> D (in melanoma; sporadic malignant;
FT                                somatic mutation).
FT                                /FTId=VAR_033138.
FT   VARIANT      67     67       L -> P (in PJS).
FT                                /FTId=VAR_006202.
FT   VARIANT      87     87       R -> K (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041139.
FT   VARIANT     135    135       G -> R (in melanoma; sporadic malignant;
FT                                somatic mutation).
FT                                /FTId=VAR_033139.
FT   VARIANT     162    164       DGL -> NDM (in PJS).
FT                                /FTId=VAR_007920.
FT   VARIANT     163    163       G -> D (in testicular tumors; a tumor
FT                                with seminoma and teratoma components;
FT                                associated with severely impaired but
FT                                detectable kinase activity; somatic
FT                                mutation).
FT                                /FTId=VAR_033140.
FT   VARIANT     194    194       D -> N (in PJS).
FT                                /FTId=VAR_007921.
FT   VARIANT     194    194       D -> Y (in melanoma; sporadic malignant;
FT                                somatic mutation).
FT                                /FTId=VAR_033141.
FT   VARIANT     239    239       W -> C (in PJS; late onset suggests
FT                                reduced penetrance).
FT                                /FTId=VAR_033142.
FT   VARIANT     247    247       Missing (in PJS).
FT                                /FTId=VAR_006203.
FT   VARIANT     297    297       R -> K (in PJS).
FT                                /FTId=VAR_007922.
FT   VARIANT     303    306       IRQH -> N (in PJS).
FT                                /FTId=VAR_033143.
FT   VARIANT     315    315       P -> S (in PJS; pathogenicity uncertain).
FT                                /FTId=VAR_033144.
FT   MUTAGEN     176    176       D->Y: Loss of kinase activity.
FT   MUTAGEN     194    194       D->A: Loss of kinase activity.
SQ   SEQUENCE   433 AA;  48636 MW;  6DF4C37AB7A89569 CRC64;
     MEVVDPQQLG MFTEGELMSV GMDTFIHRID STEVIYQPRR KRAKLIGKYL MGDLLGEGSY
     GKVKEVLDSE TLCRRAVKIL KKKKLRRIPN GEANVKKEIQ LLRRLRHKNV IQLVDVLYNE
     EKQKMYMVME YCVCGMQEML DSVPEKRFPV CQAHGYFCQL IDGLEYLHSQ GIVHKDIKPG
     NLLLTTGGTL KISDLGVAEA LHPFAADDTC RTSQGSPAFQ PPEIANGLDT FSGFKVDIWS
     AGVTLYNITT GLYPFEGDNI YKLFENIGKG SYAIPGDCGP PLSDLLKGML EYEPAKRFSI
     RQIRQHSWFR KKHPPAEAPV PIPPSPDTKD RWRSMTVVPY LEDLHGADED EDLFDIEDDI
     IYTQDFTVPG QVPEEEASHN GQRRGLPKAV CMNGTEAAQL STKSRAEGRA PNPARKACSA
     SSKIRRLSAC KQQ
//
